Ioforminol
| Code | Size | Price |
|---|
| TAR-T32177-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Ioforminol, also known as GE-145 and AN-113111, is a new low-osmolar dimeric radiographic contrast agent. GE-145 exhibits similar preclinical properties to other dimeric radiographic contrast media. In addition, the low osmolality enables an iso-osmolar formulation containing a significantly higher concentration of electrolytes than Visipaque.
CAS:
1095110-48-7
Formula:
C33H40I6N6O15
Molecular Weight:
1522.137
Purity:
0.98
SMILES:
OCC(O)CNC(=O)c1c(I)c(N(CC(O)CN(C=O)c2c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c2I)C=O)c(I)c(C(=O)NCC(O)CO)c1I
References
1. Wistrand LG, Rogstad A, Hagelin G, Roed L, Oulie I, Gram A, Evans P, Rasmussen H, Grant D, Iveson P, Newton B, Thaning M. GE-145, a new low-osmolar dimeric radiographic contrast medium. Acta Radiol. 2010 Nov;51(9):1014-20. doi: 10.3109/02841851.2010.509739. PubMed PMID: 20849319.
2. Chai CM, Rasmussen H, Eriksen M, Hvoslef AM, Evans P, Newton BB, Videm S. Predicting cardiotoxicity propensity of the novel iodinated contrast medium GE-145: Ventricular fibrillation during left coronary arteriography in pigs. Acta Radiol. 2010 Nov;51(9):1007-13. doi: 10.3109/02841851.2010.504743. PubMed PMID: 20799918.